Citation: Mh. Gail et Jp. Costantino, Validating and improving models for projecting the absolute risk of breastcancer, J NAT CANC, 93(5), 2001, pp. 334-335
Citation: R. Day et al., Tamoxifen and depression: More evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) randomized study, J NAT CANC, 93(21), 2001, pp. 1615-1623
Authors:
Reis, SE
Costantino, JP
Wickerham, DL
Tan-Chiu, E
Wang, JP
Kavanah, M
Citation: Se. Reis et al., Cardiovascular effects of tamoxifen in women with and without heart disease: Breast cancer prevention trial, J NAT CANC, 93(1), 2001, pp. 16-21
Authors:
Cushman, M
Costantino, JP
Tracy, RP
Song, K
Buckley, L
Roberts, JD
Krag, DN
Citation: M. Cushman et al., Tamoxifen and cardiac risk factors in healthy women - Suggestion of an anti-inflammatory effect, ART THROM V, 21(2), 2001, pp. 255-261
Authors:
Gail, MH
Costantino, JP
Bryant, J
Croyle, R
Freedman, L
Helzlsouer, K
Vogel, V
Citation: Mh. Gail et al., Re: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer - Response, J NAT CANC, 92(9), 2000, pp. 758-758
Authors:
Gail, MH
Costantino, JP
Bryant, J
Croyle, R
Freedman, L
Helzlsouer, K
Vogel, V
Citation: Mh. Gail et al., Re: Risk/benefit assessment of tamoxifen to prevent breast cancer - Still a work in progress?, J NAT CANC, 92(7), 2000, pp. 574-574
Authors:
Martin, TJ
Hovis, JD
Costantino, JP
Bierman, MI
Donahoe, MP
Rogers, RM
Kreit, JW
Sciurba, FC
Stiller, RA
Sanders, MH
Citation: Tj. Martin et al., A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure, AM J R CRIT, 161(3), 2000, pp. 807-813
Citation: Mh. Sanders et al., The impact of split-night polysomnography for diagnosis and positive pressure therapy titration on treatment acceptance and adherence in sleep apnea/hypopnea, SLEEP, 23(1), 2000, pp. 17-24
Authors:
Gail, MH
Costantino, JP
Bryant, J
Croyle, R
Freedman, L
Helzlsouer, K
Vogel, V
Citation: Mh. Gail et al., Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer, J NAT CANC, 91(21), 1999, pp. 1829-1846
Citation: B. Fisher et Jp. Costantino, Tamoxifen for prevention of breast cancer: Report of the national surgicaladjuvant breast and bowel project P-1 study - Response, J NAT CANC, 91(21), 1999, pp. 1891-1892
Authors:
Costantino, JP
Gail, MH
Pee, D
Anderson, S
Redmond, CK
Benichou, J
Wieand, HS
Citation: Jp. Costantino et al., Validation studies for models projecting the risk of invasive and total breast cancer incidence, J NAT CANC, 91(18), 1999, pp. 1541-1548
Authors:
Day, R
Ganz, PA
Costantino, JP
Cronin, WM
Wickerham, DL
Fisher, B
Citation: R. Day et al., Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study, J CL ONCOL, 17(9), 1999, pp. 2659-2669
Authors:
Arena, VC
Costantino, JP
Sussman, NB
Redmond, CK
Citation: Vc. Arena et al., Issues and findings in the evaluation of occupational risk among women high nickel alloys workers, AM J IND M, 36(1), 1999, pp. 114-121
Authors:
Bryant, J
Fisher, B
Gunduz, N
Costantino, JP
Emir, B
Citation: J. Bryant et al., S-phase fraction combined with other patient and tumor characteristics forthe prognosis of node-negative, estrogen-receptor-positive breast cancer, BREAST CANC, 51(3), 1998, pp. 239-253